Senior insider sale
Chief Medical Officer at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$166.6K
2.77K shares
What this filing means
KENNEY CHRISTOPHER JOHN plans to sell 2.77K shares of XENON PHARMACEUTICALS INC. valued at approximately $166.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2026ACC: 0001193125-26-100799
Officer· Chief Medical Officer
Since Aug 2021
2.77K
Shares to sell
$166.6K
Approx. market value
7.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance share unit award vesting
N/A
3/9/2026
7.50KTotal acquired7.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2026 | Performance share unit award vesting N/A | 7.50K | — |
| Total | 7.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.77K
Market value
$166.6K
3/10/2026
Total
Units
2.77K
Value
$166.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/10/2026 | 2.77K | $166.6K | NASDAQ | Planned |
| Total | 2.77K | $166.6K | ||